PDK1 and metabolic dysfunction-associated steatotic liver disease: In conclusion, MI supplementation (4 g/day) for 8 weeks along with dietary recommendations, upregulated AMPK, AKT, and PDK‐1 mRNA expression in PBMCs and manifested as improved IR indices in patients with NAFLD.